Bluebird bio has persuaded an expert committee that the benefits of its gene therapy possibility, eli-cel, exceed the risks, at...
Read more
Alnylam has outlined their strategy for delivering siRNA to the central nervous system and other organs outside of the liver....
Read more
Merck & Co. was not at all a prominent oncology player before the advent of Keytruda. The New Jersey drugmaker wants...
Read more
Roche is exploring new products to refill its blood cancer armoury after Rituxan's patent expiration. Swiss pharma is launching a...
Read more
It was a small study, with only 18 rectal cancer sufferers taking the same medicine. However, the outcomes were astounding....
Read more
The findings of a phase 1 trial examining a medication mixture targeting multiple mutant variants of cancer's 'death star' protein...
Read more
The Indian Council of Medical Research, the country's apex agency for biomedical research, has issued guidelines for the use of...
Read more
Cyberattacks affect everyone, including pharmaceutical behemoths like Novartis. The week ending June 4th, specialised IT website Bleeping Computer revealed that...
Read more
COVID-19's propensity to fuel domestic drug production hasn't waned two years into the pandemic. Take, for example, Pfizer's new $120...
Read more
Even though the company's analysis found it could reduce the likelihood of mild-to-severe disease, the US Food and Drug Administration...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
